Donidalorsen
Alternative Names: Odzorna
Donidalorsen is a medication used to prevent hereditary angioedema attacks. It is an antisense oligonucleotide that works by reducing the production of prekallikrein, a protein involved in generating bradykinin, which causes swelling in HAE. By lowering bradykinin levels, donidalorsen helps reduce the frequency and severity of attacks. It is given as a subcutaneous injection, typically every 4 to 8 weeks. Donidalorsen is used for long-term prevention, not for treating acute HAE attacks.
Treatment Type: Prescription Medication
Treatment Class: N/A
Treatment Modality: Injection
Review Summary
Based on the provided information, there are no user reviews available for the treatment 'Donidalorsen' against the disease 'Hereditary Angioedema'. The author has not provided any review or rating for this treatment, making it difficult to assess its effectiveness without further data.
This summary was generated by users' reviews
Breakdown by Category
Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.
Explore various treatment options to empower yourself in making a well-informed choice.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
AI Summary of User Experiences
Not medical advice.
Based on the provided information, there are no user reviews available for the treatment 'Donidalorsen' against the disease 'Hereditary Angioedema'. The author has not provided any review or rating for this treatment, making it difficult to assess its effectiveness without further data.
Reviews
Filter by reviewer type Pro